$5.4001
-0.0499[-0.92%]
At close: Apr 22
$5.4001
0[0.00%]
PreMarket: 7:30PM EDT
Windtree Therapeutics
(NASDAQ:WINT)Windtree Therapeutics Stock (NASDAQ:WINT), Quotes and News Summary
Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 11.000 / 14.006K |
| Day Range | - - - |
| 52 Wk Range | 4.777 - 44.460 |
| Market Cap | $2.755M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 34 |
| Short Interest | 7.81% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Windtree Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innov...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Windtree Therapeutics (WINT) stock?
You can purchase shares of Windtree Therapeutics (NASDAQ: WINT) through any online brokerage.
Who are Windtree Therapeutics's (WINT) competitors?
Other companies in Windtree Therapeutics’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Geovax Labs (NASDAQ:GOVX) and Finch Therapeutics Gr (NASDAQ:FNCH).
What is the target price for Windtree Therapeutics (WINT) stock?
The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by HC Wainwright & Co. on Wednesday, January 3, 2024. The analyst firm set a price target for 1.00 expecting WINT to fall to within 12 months (a possible -81.48% downside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Windtree Therapeutics (WINT)?
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $5.4001 last updated April 22, 2024 at 7:30 PM EDT.
Does Windtree Therapeutics (WINT) pay a dividend?
There are no upcoming dividends for Windtree Therapeutics.
When is Windtree Therapeutics (NASDAQ:WINT) reporting earnings?
Windtree Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
Is Windtree Therapeutics (WINT) going to split?
There is no upcoming split for Windtree Therapeutics.
What sector and industry does Windtree Therapeutics (WINT) operate in?
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.